Atm and cellular response to DNA damage.
Lavin
Martin F
MF
Radiation Biology and Oncology, The Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Herston, Queensland, Australia.
Kozlov
Sergei
S
Gueven
Nuri
N
Peng
Cheng
C
Birrell
Geoff
G
Chen
Phillip
P
Scott
Shaun
S
D000818:Animals; D001260:Ataxia Telangiectasia; D064007:Ataxia Telangiectasia Mutated Proteins; D002453:Cell Cycle; D018797:Cell Cycle Proteins / Q000235:genetics / Q000378:metabolism*; D002467:Cell Nucleus / Q000378:metabolism*; D004249:DNA Damage; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D018816:Genes, cdc; D020022:Genetic Predisposition to Disease; D042822:Genomic Instability; D006579:Heterozygote; D006801:Humans; D008954:Models, Biological; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000378:metabolism*; D025521:Tumor Suppressor Proteins / Q000235:genetics / Q000378:metabolism*
D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D025521:Tumor Suppressor Proteins; C576324:ATM protein, human; D064007:Ataxia Telangiectasia Mutated Proteins; D017346:Protein Serine-Threonine Kinases